Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, January 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 101 articles:
HTML format


 

Single Articles

  1. OROIAN BA, Ciobica A, Timofte D, Stefanescu C, et al
    New Metabolic, Digestive, and Oxidative Stress-Related Manifestations Associated with Posttraumatic Stress Disorder.
    Oxid Med Cell Longev. 2021;2021:5599265.
    PubMed    
    Abstract available

  2. VAN OUYTSEL P, Szalai A, Van Gossum A, Arvanitakis M, et al
    Feasibility of a low FODMAPs diet without initial dietician intervention in the management of patients with irritable bowel syndrome: a prospective study.
    Acta Gastroenterol Belg. 2021;84:593-600.
    PubMed    
    Abstract available

  3. MOKHTAR NM, Jaafar NM, Alfian E, Mohd Rathi ND, et al
    Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink.
    Acta Gastroenterol Belg. 2021;84:585-591.
    PubMed    
    Abstract available

  4. VAN NIEUWENHOVE T, Rasschaert G, Kharagjitsingh A, Keymeulen B, et al
    The prevalence of disorders of the gut-brain axis in type 2 diabetes mellitus patients with metabolic dysfunction-associated fatty liver disease: an observational study.
    Acta Gastroenterol Belg. 2021;84:541-547.
    PubMed    
    Abstract available

  5. LIN H, Guo Q, Wen Z, Tan S, et al
    The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Microb Cell Fact. 2021;20:233.
    PubMed    
    Abstract available

  6. SCHNEIDER E, Sabate JM, Bouchoucha M, Hercberg S, et al
    Fermentable Oligo-, Di-, and Mono-Saccharides and Polyols (FODMAPs) Consumption and Irritable Bowel Syndrome in the French NutriNet-Sante Cohort.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  7. PICCIONE M, Facchinello N, Schrenk S, Gasparella M, et al
    STW 5 Herbal Preparation Modulates Wnt3a and Claudin 1 Gene Expression in Zebrafish IBS-like Model.
    Pharmaceuticals (Basel). 2021;14.
    PubMed    
    Abstract available

  8. BAKSHI HA, Quinn GA, Aljabali AAA, Hakkim FL, et al
    Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon.
    Pharmaceuticals (Basel). 2021;14.
    PubMed    
    Abstract available

  9. WOLLNY T, Daniluk T, Piktel E, Wnorowska U, et al
    Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome.
    Pathogens. 2021;10.
    PubMed    
    Abstract available

  10. BONFIGLIO F, Liu X, Smillie C, Pandit A, et al
    GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome.
    Cell Genom. 2021;1:None.
    PubMed    
    Abstract available

  11. HUANG J, Lu M, Zheng Y, Ma J, et al
    Quality of Evidence Supporting the Role of Acupuncture for the Treatment of Irritable Bowel Syndrome.
    Pain Res Manag. 2021;2021:2752246.
    PubMed    
    Abstract available

  12. FISCHER S, Skoluda N, Ali N, Nater UM, et al
    Hair cortisol levels in women with medically unexplained symptoms.
    J Psychiatr Res. 2021;146:77-82.
    PubMed    
    Abstract available

  13. WADI WF, Rathi MH, Molan AL
    The possible link between intestinal parasites and irritable bowel syndrome (IBS) in Diyala Province, Iraq.
    Ann Parasitol. 2021;67:505-513.
    PubMed    
    Abstract available

  14. KLEYKAMP BA, Ferguson MC, McNicol E, Bixho I, et al
    The prevalence of comorbid chronic pain conditions among patients with temporomandibular disorders: A systematic review.
    J Am Dent Assoc. 2021 Dec 21. pii: S0002-8177(21)00518.
    PubMed    
    Abstract available

  15. JANSSON-KNODELL CL, White M, Lockett C, Xu H, et al
    Associations of Food Intolerance with Irritable Bowel Syndrome, Psychological Symptoms, and Quality of Life.
    Clin Gastroenterol Hepatol. 2021 Dec 21. pii: S1542-3565(21)01345.
    PubMed    
    Abstract available

  16. WANG X, Xiao Y, Xu X, Guo L, et al
    Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease.
    Front Cell Infect Microbiol. 2021;11:711884.
    PubMed    
    Abstract available

  17. OSTNER J, Carcy S, Muller CL
    tascCODA: Bayesian Tree-Aggregated Analysis of Compositional Amplicon and Single-Cell Data.
    Front Genet. 2021;12:766405.
    PubMed    
    Abstract available

  18. DICKS LMT, Hurn D, Hermanus D
    Gut Bacteria and Neuropsychiatric Disorders.
    Microorganisms. 2021;9.
    PubMed    
    Abstract available

  19. LOOSEN SH, Jordens MS, Luedde M, Modest DP, et al
    Incidence of Cancer in Patients with Irritable Bowl Syndrome.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  20. GRINSVALL C, Van Oudenhove L, Dupont P, Ryu HJ, et al
    Altered Structural Covariance of Insula, Cerebellum and Prefrontal Cortex Is Associated with Somatic Symptom Levels in Irritable Bowel Syndrome (IBS).
    Brain Sci. 2021;11.
    PubMed    
    Abstract available

  21. SANDHU A, Chopra T
    Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls.
    Therap Adv Gastroenterol. 2021;14:17562848211053105.
    PubMed    
    Abstract available

  22. DAVOODVANDI A, Fallahi F, Tamtaji OR, Tajiknia V, et al
    An Update on the Effects of Probiotics on Gastrointestinal Cancers.
    Front Pharmacol. 2021;12:680400.
    PubMed    
    Abstract available

  23. LEE JY, Kim N, Park JH, Yu JE, et al
    Sex and Gender Differences in Overlap Syndrome of Functional Gastrointestinal Disorder and Effect of Genetic Polymorphisms in South Korea: A Long-term Follow-up Study.
    J Neurogastroenterol Motil. 2022;28:145-158.
    PubMed    
    Abstract available

  24. ZHU C, Wang X, Li J, Jiang R, et al
    Determine independent gut microbiota-diseases association by eliminating the effects of human lifestyle factors.
    BMC Microbiol. 2022;22:4.
    PubMed    
    Abstract available

  25. PONTET Y, Olano C
    [Irritable bowel syndrome prevalence in Latin America].
    Rev Gastroenterol Peru. 2021;41:144-149.
    PubMed    
    Abstract available

  26. RASTGOO S, Ebrahimi-Daryani N, Agah S, Karimi S, et al
    Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management.
    Front Nutr. 2021;8:746703.
    PubMed    
    Abstract available

  27. MARLICZ W, Skonieczna-Zydecka K, Krynicka P, Loniewski I, et al
    Probiotics in irritable bowel syndrome - is the quest for the right strain over? Rapid review of existing guidelines and recommendations.
    Prz Gastroenterol. 2021;16:369-382.
    PubMed    
    Abstract available

  28. BECKERS AB, Wilms E, Mujagic Z, Kajtar B, et al
    Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients.
    Front Pharmacol. 2021;12:806002.
    PubMed    
    Abstract available

  29. LAI YT, Chen CY, Bair MJ
    Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan.
    Front Pharmacol. 2021;12:788795.
    PubMed    
    Abstract available

  30. GORGILI K, Artemiadis A, Bacopoulou F, Karatzas P, et al
    The Effects of Pythagorean Self-Awareness Intervention on Irritable Bowel Syndrome Patients: A Non-randomized Controlled Trial.
    Adv Exp Med Biol. 2021;1337:345-354.
    PubMed    
    Abstract available

  31. MOHAMMED AA, Moustafa HA, Nour-Eldein H, Saudi RA, et al
    Association of anxiety-depressive disorders with irritable bowel syndrome among patients attending a rural family practice center: a comparative cross-sectional study.
    Gen Psychiatr. 2021;34:e100553.
    PubMed    
    Abstract available

  32. JAMALIZADEH H, Ahmadi B, Shariffar F, Ansari M, et al
    Clinical evaluation of the effect of Zataria multiflora Boiss and Trachyspermum copticum (L.) on the patients with irritable bowel syndrome.
    Explore (NY). 2021 Dec 13. pii: S1550-8307(21)00251.
    PubMed    
    Abstract available

  33. ZAKI SA, Helal ME, Rashid A
    Cardiovascular Toxicity Due to Otilonium Bromide Overdose: A Case Report.
    J Emerg Med. 2022 Jan 11. pii: S0736-4679(21)00775.
    PubMed    
    Abstract available

  34. ROCKEFELLER NF, Petersen TR, Jeppson PC, Dunivan G, et al
    Midurethral Sling Removal or Revision in Women with Chronic Pain.
    Female Pelvic Med Reconstr Surg. 2022 Jan 13. pii: 01436319-900000000-99171.
    PubMed    
    Abstract available

  35. BRYAN R, Beitz JM
    Critical Connections Among Embedding of Childhood Adversity and Adult Chronic Gastrointestinal and Genitourinary Disorders: A Review of the Literature.
    Wound Manag Prev. 2021;67:33-47.
    PubMed    
    Abstract available

  36. PRETORIUS L, Van Staden ADP, Van der Merwe JJ, Henning N, et al
    Alterations to microbial secretome by estrogen may contribute to sex bias in irritable bowel syndrome.
    Inflammopharmacology. 2022 Jan 13. pii: 10.1007/s10787-021-00906.
    PubMed    
    Abstract available

  37. PENG L, Fang J, Dai N, Shen X, et al
    Efficacy and Safety of Linaclotide in Patients with Irritable Bowel Syndrome with Constipation: Chinese Sub-Cohort Analysis of a Phase III, Randomized, Double-Blind, Placebo-controlled Trial.
    J Dig Dis. 2022 Jan 12. doi: 10.1111/1751-2980.13081.
    PubMed    
    Abstract available

  38. SINGH P, Alm EJ, Kelley JM, Cheng V, et al
    Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.
    Gut Microbes. 2022;14:2020067.
    PubMed    
    Abstract available

  39. KHODABAKHSH P, Khoie N, Dehpour AR, Abdollahi A, et al
    Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-kappaB signaling in an experimental model.
    Inflammopharmacology. 2022 Jan 10. pii: 10.1007/s10787-021-00907.
    PubMed    
    Abstract available

  40. ALKALAY MJ
    Nutrition in Patients with Lactose Malabsorption, Celiac Disease, and Related Disorders.
    Nutrients. 2021;14.
    PubMed    
    Abstract available

  41. PATCHARATRAKUL T, Linlawan S, Plaidum S, Gonlachanvit S, et al
    The Effect of Rice vs. Wheat Ingestion on Postprandial Gastroesophageal Reflux (GER) Symptoms in Patients with Overlapping GERD-Irritable Bowel Syndrome (IBS).
    Foods. 2021;11.
    PubMed    
    Abstract available

  42. KIM S, Keum B, Byun J, Kim B, et al
    Colonic Mucosal Immune Activation in Mice with Ovalbumin-Induced Allergic Airway Disease: Association between Allergic Airway Disease and Irritable Bowel Syndrome.
    Int J Mol Sci. 2021;23.
    PubMed    
    Abstract available

  43. LENGLART L, Raieli V, Sciruicchio V, Caula C, et al
    The association between gastro-oesophageal reflux and migraine in the paediatric population: a multicentre case-control study.
    Eur J Pediatr. 2022 Jan 10. pii: 10.1007/s00431-021-04368.
    PubMed    
    Abstract available

  44. GOTTSCHALK L, Andresen V, Layer P
    [Irritable bowel syndrome and functional dyspepsia : Diagnosis and treatment].
    Internist (Berl). 2022;63:51-61.
    PubMed    
    Abstract available

  45. LOFTUS CG, Ebbert JO, Aakre CA, Caine NA, et al
    Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain Conditions.
    Mayo Clin Proc Innov Qual Outcomes. 2021;6:45-54.
    PubMed    
    Abstract available

  46. MCQUEENIE R, Jani BD, Siebert S, McLoone P, et al
    Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank.
    J Comorb. 2021;11:26335565211005870.
    PubMed    
    Abstract available

  47. LAYER P, Andresen V, Allescher H, Bischoff SC, et al

    Z Gastroenterol. 2021;59:1323-1415.
    PubMed    


  48. DAI YQ, Weng H, Wang Q, Guo XJ, et al
    Moxibustion for diarrhea-predominant irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Complement Ther Clin Pract. 2022;46:101532.
    PubMed    
    Abstract available

  49. VAN MEGEN F, Skodje GI, Lergenmuller S, Zuhlke S, et al
    A low FODMAP diet reduces symptoms in treated celiac patients with ongoing symptoms - a randomized controlled trial.
    Clin Gastroenterol Hepatol. 2022 Jan 17. pii: S1542-3565(22)00034.
    PubMed    
    Abstract available

  50. MEARIN F, Sans M, Balboa A
    Relevance and needs of Irritable Bowel Syndrome (IBS): comparison with Inflammatory Bowel Disease (IBD).
    Gastroenterol Hepatol. 2022 Jan 17. pii: S0210-5705(21)00332.
    PubMed    
    Abstract available

  51. CHUAH KH, Cheong SY, Lim SZ, Mahadeva S, et al
    Functional Dyspepsia Leads to More Healthcare Utilization in Secondary Care Compared with Other Functional Gastrointestinal Disorders.
    J Dig Dis. 2022 Jan 20. doi: 10.1111/1751-2980.13082.
    PubMed    
    Abstract available

  52. HAN G, Ko SJ, Kim K, Jun H, et al
    The efficacy of the traditional Korean herbal medicine Tongsayobang for the treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e28116.
    PubMed    
    Abstract available

  53. WANG H, Labus JS, Griffin F, Gupta A, et al
    Functional brain rewiring and altered cortical stability in ulcerative colitis.
    Mol Psychiatry. 2022 Jan 19. pii: 10.1038/s41380-021-01421.
    PubMed    
    Abstract available

  54. YAMAMOTO Y, Furukawa S, Watanabe J, Miyake T, et al
    Association between menstrual pain and functional dyspepsia in a Japanese young population.
    Neurogastroenterol Motil. 2022 Jan 19:e14324. doi: 10.1111/nmo.14324.
    PubMed    
    Abstract available

  55. CHE X, Brydges CR, Yu Y, Price A, et al
    Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    medRxiv. 2022 Jan 11. doi: 10.1101/2021.06.14.21258895.
    PubMed    
    Abstract available

  56. HORIE H, Handa O, Naito Y, Majima A, et al
    Subepithelial Serotonin Reduces Small Intestinal Epithelial Cell Tightness via Reduction of Occluding Expression.
    Turk J Gastroenterol. 2022;33:74-79.
    PubMed    
    Abstract available

  57. GUVEN IE, Baspinar B, Atalay R
    Relationship Between Systemic Immune-Inflammation Index and Irritable Bowel Syndrome.
    Turk J Gastroenterol. 2022;33:30-34.
    PubMed    
    Abstract available

  58. KLEPPE MM, Bronstad I, Lied GA, Danielsen Y, et al
    Intestinal barrier integrity in anorexia nervosa (a pilot study).
    Int J Eat Disord. 2022 Jan 17. doi: 10.1002/eat.23678.
    PubMed    
    Abstract available

  59. HUNT MG, Dalvie A, Ipek S, Wasman B, et al
    Acceptability and efficacy of the Zemedy app versus a relaxation training and meditation app for IBS: protocol for a randomised controlled trial.
    BMJ Open. 2022;12:e055014.
    PubMed    
    Abstract available

  60. NYBACKA S, Tornblom H, Simren M, Storsrud S, et al
    The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options.
    JMIR Res Protoc. 2022;11:e31413.
    PubMed    
    Abstract available

  61. YUAN F, Ren H, Tan W, Wang Y, et al
    Effect of phosphodiesterase-4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model.
    Neurogastroenterol Motil. 2022 Jan 17:e14317. doi: 10.1111/nmo.14317.
    PubMed    
    Abstract available

  62. SUN H, Li X, Chen W, Jia F, et al
    Effect of probiotics and dietary fiber combined with pinaverium bromide on intestinal flora in patients with irritable bowel syndrome.
    Am J Transl Res. 2021;13:14039-14045.
    PubMed    
    Abstract available

  63. HU P, Sun K, Li H, Qi X, et al
    Transcutaneous Electrical Acustimulation Improved the Quality of Life in Patients With Diarrhea-Irritable Bowel Syndrome.
    Neuromodulation. 2021 Dec 18. pii: S1094-7159(21)06184.
    PubMed    
    Abstract available

  64. BIN ABDULRAHMAN KA, Alenazi NS, Albishri SB, Alshehri FF, et al
    Association of Migraine and Irritable Bowel Syndrome in Saudi Arabia: A Nationwide Survey.
    Biomed Res Int. 2022;2022:8690562.
    PubMed    
    Abstract available

  65. KIM KO
    [Functional Gastrointestinal Disorders in Patients with Inflammatory Bowel Disease].
    Korean J Gastroenterol. 2022;79:4-11.
    PubMed    
    Abstract available

  66. JOSHEE S, Lim L, Wybrecht A, Berriesford R, et al
    Meta-analysis and systematic review of the association between adverse childhood events and irritable bowel syndrome.
    J Investig Med. 2022 Jan 27. pii: jim-2021-002109. doi: 10.1136/jim-2021-002109.
    PubMed    
    Abstract available

  67. MOSHIREE B, Schoenfeld P, Franklin H, Rezaie A, et al
    The Effect of Acid Suppression Therapy on the Safety and Efficacy of Plecanatide: Analysis of Randomized Phase III Trials.
    Clin Ther. 2022 Jan 24. pii: S0149-2918(21)00462.
    PubMed    
    Abstract available

  68. LIU JX, Yin MM, Gao YL, Shang J, et al
    MSF-LRR: Multi-similarity Information Fusion through Low-Rank Representation to Predict Disease-associated Microbes.
    IEEE/ACM Trans Comput Biol Bioinform. 2022;PP.
    PubMed    
    Abstract available

  69. TIKUNOV AY, Shvalov AN, Morozov VV, Babkin IV, et al
    Taxonomic composition and biodiversity of the gut microbiome from patients with irritable bowel syndrome, ulcerative colitis, and asthma.
    Vavilovskii Zhurnal Genet Selektsii. 2021;25:864-873.
    PubMed    
    Abstract available

  70. LEE J, Park SB, Kim HW, Lee HS, et al
    Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study.
    Gastroenterol Res Pract. 2022;2022:9872230.
    PubMed    
    Abstract available

  71. SHEHATA E, Parker A, Suzuki T, Swann JR, et al
    Microbiomes in physiology: Insights into 21(st) century global medical challenges.
    Exp Physiol. 2022 Jan 26. doi: 10.1113/EP090226.
    PubMed    
    Abstract available

  72. CHEN J, Barandouzi ZA, Lee J, Xu W, et al
    Psychosocial and Sensory Factors Contribute to Self-Reported Pain and Quality of Life in Young Adults with Irritable Bowel Syndrome.
    Pain Manag Nurs. 2022 Jan 21. pii: S1524-9042(21)00264.
    PubMed    
    Abstract available

  73. SPERBER AD, Freud T, Abu-Freha N, Shibli F, et al
    Epidemiology of disorders of Gut-Brain interaction in Israel: Results from the Rome Foundation global epidemiology study.
    Neurogastroenterol Motil. 2022 Jan 24:e14323. doi: 10.1111/nmo.14323.
    PubMed    
    Abstract available

  74. PURSSELL H, Whorwell PJ, Athwal VS, Vasant DH, et al
    Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?
    World J Hepatol. 2021;13:1816-1827.
    PubMed    
    Abstract available

  75. VLASIE A, Trifu SC, Lupuleac C, Kohn B, et al
    Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review).
    Exp Ther Med. 2022;23:185.
    PubMed    
    Abstract available

  76. FUJIMORI S
    Progress in elucidating the relationship between Helicobacter pylori infection and intestinal diseases.
    World J Gastroenterol. 2021;27:8040-8046.
    PubMed    
    Abstract available

  77. NIKOLOVA VL, Pelton L, Moulton CD, Zorzato D, et al
    The prevalence and incidence of irritable bowel syndrome and inflammatory bowel disease in depression and bipolar disorder: a systematic review and meta-analysis.
    Psychosom Med. 2022 Jan 20. pii: 00006842-900000000-98344.
    PubMed    
    Abstract available

  78. SU C, Liu W, Wang Q, Qiu S, et al
    Abnormal resting-state local spontaneous functional activity in irritable bowel syndrome patients: A meta-analysis.
    J Affect Disord. 2022 Jan 20. pii: S0165-0327(22)00085.
    PubMed    
    Abstract available

  79. MOHSENI F, Agah S, Ebrahimi-Daryani N, Taher M, et al
    The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial.
    Clin Nutr ESPEN. 2022;47:45-50.
    PubMed    
    Abstract available

  80. COLOMIER E, Van Oudenhove L, Tack J, Bohn L, et al
    Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  81. TKACH S, Dorofeyev A, Kuzenko I, Boyko N, et al
    Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  82. KUMRIC M, Zivkovic PM, Ticinovic Kurir T, Vrdoljak J, et al
    Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease.
    Diagnostics (Basel). 2021;12.
    PubMed    
    Abstract available

  83. THAVAMANI A, Umapathi KK, Khatana J, Bhandari S, et al
    Cyclic Vomiting Syndrome-Related Hospitalizations Trends, Comorbidities & Health Care Costs in Children: A Population Based Study.
    Children (Basel). 2022;9.
    PubMed    
    Abstract available

  84. BRAR MS, de Buck van Overstraeten A, Baxter NN
    Rectal Cancer Incidence is Low Following Rectal Diversion or Subtotal Colectomy for IBD: Results of a Population-based Study.
    J Crohns Colitis. 2021;15:1787-1798.
    PubMed    
    Abstract available

  85. PAINE P
    Review article: current and future treatment approaches for pain in IBS.
    Aliment Pharmacol Ther. 2021;54 Suppl 1:S75-S88.
    PubMed    
    Abstract available

  86. SPIEGEL BMR, Liran O, Gale R, Khalil C, et al
    QUALITATIVE VALIDATION OF A NOVEL VIRTUAL REALITY (VR) PROGRAM FOR IRRITABLE BOWEL SYNDROME: A VR1 STUDY.
    Am J Gastroenterol. 2022 Jan 7. pii: 00000434-990000000-00189.
    PubMed    
    Abstract available

  87. SCARLATA K, Eswaran S, Baker JR, Chey WD, et al
    Utilization of Dietitians in the Management of Irritable Bowel Syndrome by Members of the American College of Gastroenterology.
    Am J Gastroenterol. 2022 Jan 11. pii: 00000434-990000000-00184.
    PubMed    
    Abstract available

  88. GUZMAN-CARCAMO A, Navarro Gerrard C, Severino Ferreras I, Lopez Gomez J, et al
    P073 Diagnostic Outcome of Patients With Non-Specific Colitis.
    Am J Gastroenterol. 2021;116.
    PubMed    
    Abstract available

  89. GUEORGUIEVA I, Jacobs R, Piper M
    P019 Not All Fecal Calprotectin is Specific for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021;116.
    PubMed    
    Abstract available

  90. REZAZADEGAN M, Soheilipour M, Tarrahi MJ, Amani R, et al
    Correlation Between Zinc Nutritional Status with Serum Zonulin and Gastrointestinal Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome: A Case-Control Study.
    Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07368.
    PubMed    
    Abstract available

  91. SHAH ED
    Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 Jan 11. pii: 10.1007/s10620-021-07369.
    PubMed    


  92. KNOWLES SR, Apputhurai P, Burgell RE, Keefer L, et al
    Development and Validation of the Gastrointestinal Unhelpful Thinking Scale (GUTs): A Brief Self-Report Measure for Clinical and Research Settings.
    Gastroenterol Nurs. 2022 Jan 10. pii: 00001610-900000000-99858.
    PubMed    
    Abstract available

  93. DEB B, Sharma M, Fletcher JG, Srinivasan SG, et al
    Inadequate Rectal Pressure and Insufficient Relaxation and Abdominopelvic Coordination in Defecatory Disorders.
    Gastroenterology. 2021 Dec 21. pii: S0016-5085(21)04093.
    PubMed    
    Abstract available

  94. CHANG L
    How to Approach a Patient with Difficult-to-Treat IBS.
    Gastroenterology. 2021;161:1092-1098.
    PubMed    


  95. ZHENG T, Camargo-Tavares L, Bonfiglio F, Marques FZ, et al
    Rare Hypomorphic Sucrase Isomaltase Variants in Relation to Irritable Bowel Syndrome Risk in UK Biobank.
    Gastroenterology. 2021;161:1712-1714.
    PubMed    


  96. CAMILLERI M
    New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders.
    Gastroenterology. 2021;161:761-764.
    PubMed    


  97. BLACK CJ, Ford AC
    Assessing the Impact of Changes to the Rome IV Criteria for Clinical Practice in Irritable Bowel Syndrome.
    Gastroenterology. 2022 Jan 22. pii: S0016-5085(22)00037.
    PubMed    


  98. KEARNEY DJ, Kamp KJ, Storms M, Simpson TL, et al
    Prevalence of Gastrointestinal Symptoms and Irritable Bowel Syndrome Among Individuals With Symptomatic Posttraumatic Stress Disorder.
    J Clin Gastroenterol. 2022 Jan 28. pii: 00004836-900000000-97319.
    PubMed    
    Abstract available

  99. GIBSON PR, Halmos EP, So D, Yao CK, et al
    DIET AS A THERAPEUTIC TOOL IN CHRONIC GASTROINTESTINAL DISORDERS - LESSONS FROM THE FODMAP JOURNEY.
    J Gastroenterol Hepatol. 2022 Jan 6. doi: 10.1111/jgh.15772.
    PubMed    
    Abstract available

  100. REJ A, Sanders DS, Buckle RL, Trott N, et al
    What is the optimal FODMAP threshold in IBS?
    J Gastroenterol Hepatol. 2021;36:1723-1725.
    PubMed    


  101. KO C, Lucassen P, van der Linden B, Ballering A, et al
    Stigma perceived by patients with functional somatic syndromes and its effect on health outcomes - A systematic review.
    J Psychosom Res. 2022;154:110715.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;